Low-dose OKT3 is not effective in the treatment of steroid-resistant acute renal allograft rejections

被引：1
作者：
Lye, WC
Vathsala, A
Lee, WT
Leong, SO
机构：
[1] Natl Univ Singapore Hosp, Dept Med, Singapore 117548, Singapore
[2] Singapore Gen Hosp, Singapore 0316, Singapore
来源：
TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(98)00951-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3106 / 3107
页数：2
相关论文
共 6 条
[1]  
ALLOWAY R, 1992, CLIN TRANSPLANT, V46, P468
[2]   TREATMENT OF ACUTE RENAL-ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL-ANTIBODY [J].
COSIMI, AB ;
BURTON, RC ;
COLVIN, RB ;
GOLDSTEIN, G ;
DELMONICO, FL ;
LAQUAGLIA, MP ;
TOLKOFFRUBIN, N ;
RUBIN, RH ;
HERRIN, JT ;
RUSSELL, PS .
TRANSPLANTATION, 1981, 32 (06) :535-540
[3]   Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection [J].
Midtvedt, K ;
Tafjord, AB ;
Hartmann, A ;
Eide, TC ;
Holdaas, H ;
Nordal, KP ;
Draganov, B ;
Sodal, G ;
Leivestad, T ;
Fauchald, P .
TRANSPLANTATION, 1996, 62 (01) :38-42
[4]   THE USE OF OKT3 IN CADAVERIC RENAL-TRANSPLANTATION FOR REJECTION THAT IS UNRESPONSIVE TO CONVENTIONAL ANTI-REJECTION THERAPY [J].
NORMAN, DJ ;
BARRY, JM ;
BENNETT, WM ;
LEONE, M ;
HENELL, K ;
FUNNELL, B ;
HUBERT, B .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (02) :90-93
[5]  
NORMAN DJ, 1991, TRANSPLANT P, V23, P1052
[6]  
PONTICELLI C, 1987, TRANSPLANT P, V19, P1908
1